Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
{{output}}
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global pandemic. Many drugs without established efficacy are being used to treat COVID-19 patients either as an offlabel/compassionate use or as a clinical trial. Although drug re... ...
